Remdesivir, an anti-viral drug that was given to President Donald Trump while he recovered from COVID-19, has “little or no effect” on patients’ ultimate survival, a study by the World Health Organization (WHO) claims. Three other drugs that have also been used to treat individuals sickened by the pathogen also failed to produce meaningful results.
As BBC News reported, the WHO carried out its Solidarity study, in which it looked at four drugs that doctors across the world have used in trying to treat patients ill with the sometimes-fatal respiratory illness caused by the novel coronavirus. In addition to remdesivir, a drug usually used to treat Ebola, and which has been around for decades, the organization also reviewed the anti-malaria medicine hydroxychloroquine, the auto-immune treatment interferon, and the HIV-fighting cocktail of lopinavir and ritonavir.
Specifically, the survey looked at 11,266 adult patients in total, across 500 hospitals in more than 30 different countries, all of whom were given one or more of the experimental treatments.
0 comments :
Post a Comment